AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 37 filers reported holding AXSOME THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 0.22 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $1,821,000 | +923.0% | 128,000 | +103.2% | 0.02% | +1050.0% |
| Q4 2018 | $178,000 | -41.4% | 63,000 | -28.4% | 0.00% | -33.3% |
| Q3 2018 | $304,000 | +7.8% | 88,000 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $282,000 | +30.6% | 88,000 | 0.0% | 0.00% | +50.0% |
| Q1 2018 | $216,000 | -22.9% | 88,000 | +76.0% | 0.00% | -33.3% |
| Q4 2017 | $280,000 | +0.7% | 50,000 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $278,000 | – | 50,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 1,132,645 | $37,332,000 | 32.86% |
| MORGAN JESS S & CO INC | 113,430 | $3,739,000 | 2.47% |
| Fairmount Funds Management LLC | 187,598 | $6,183,000 | 2.25% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 1,423,653 | $46,924,000 | 1.43% |
| WMS Partners, LLC | 250,000 | $8,240,000 | 1.21% |
| Beck Bode, LLC | 102,127 | $3,366,000 | 0.94% |
| RTW INVESTMENTS, LP | 1,616,497 | $53,280,000 | 0.80% |
| MPM BioImpact LLC | 110,155 | $3,631,000 | 0.56% |
| Endurant Capital Management LP | 52,048 | $1,716,000 | 0.39% |
| Bellevue Group AG | 752,945 | $24,817,000 | 0.25% |